Tigulixostat - LG Chem
Alternative Names: IBI-350; LC-350189; LR-19074Latest Information Update: 28 Aug 2024
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Antigouts; Carboxylic acids; Indoles; Nitriles; Pyrazoles; Small molecules
- Mechanism of Action Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Gout
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for phase-I development in Gout(In volunteers) in USA (PO, Capsule)
- 28 Aug 2024 No recent reports of development identified for phase-I development in Gout(In volunteers) in USA (PO, Tablet)
- 12 Jun 2024 Pharmacodynamics data from preclinical studies in Gout presented at the 25th Annual Congress of the European League Against Rheumatism (EULAR-2024)